slide1
Download
Skip this Video
Download Presentation
H. Awuoche 1 , G.Kiringa 1 , V. Nduba 1 , E. Mitchell 2

Loading in 2 Seconds...

play fullscreen
1 / 5

H. Awuoche 1 , G.Kiringa 1 , V. Nduba 1 , E. Mitchell 2 - PowerPoint PPT Presentation


  • 105 Views
  • Uploaded on

H. Awuoche 1 , G.Kiringa 1 , V. Nduba 1 , E. Mitchell 2 1 KEMRI/CDC Research and Public Health Collaboration 2 KNCV Dutch Tuberculosis Foundation XIX International AIDS Society Conference Walter E. Washington Convention Centre, Washington, D.C 22 nd -27 th July 2012.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' H. Awuoche 1 , G.Kiringa 1 , V. Nduba 1 , E. Mitchell 2' - minda


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

H. Awuoche1, G.Kiringa1, V. Nduba1, E. Mitchell2

1 KEMRI/CDC Research and Public Health Collaboration

2KNCV Dutch Tuberculosis Foundation

XIX International AIDS Society Conference

Walter E. Washington Convention Centre, Washington, D.C

22nd-27th July 2012

Cost Effectiveness of Two Transport Strategies for Retention of Young Mothers and Infants Enrolled in a TB Vaccine Trial
the critical role of transport reimbursement
The Critical Role of Transport Reimbursement

‘Research participants may be reimbursed for their transport and other expenses including lost earnings associated with their participation in research’ (CIOMS guidelines 2002)

Transport reimbursement caters for costs incurred by study participants when travelling for clinic visits.

It is a critical tool in subject retention and motivation to continued study participation.

Additionally, it increases access to health care in our settings where distance to health facilities impedes health seeking behavior, thereby reducing infant mortality

conclusion
Conclusion

Using ethically approved rates, there’s risk of under-compensation

Despite under-compensation, retention rate was high but at a cost three times higher than directly reimbursing the participants.

Limitations: there is need to conduct formative studies to understand the views of potential participants on under compensation and the effects on study endpoints and retention

There is also need for continued dialogue between investigators and Ethical Committees

There is room for continued education of participants on research ethics and non monetary benefits of research participation

slide5

Acknowledgement

  • Study participants - NOCHAK study
  • Residents of the two communities
  • Research staff team – NOCHAK study
  • Co-authors
  • Directors –Kenya Medical Research Institute/Centers for Disease Control and Prevention
  • Sponsor – AERAS
ad